Keratinized Tissue

Keratinized tissue is the firm, stippled gingival tissue that tightly adheres to the underlying alveolar bone around natural teeth and dental implants. Toughened by the protein keratin, this tissue forms a durable barrier that resists the mechanical forces of chewing and brushing while preventing bacterial penetration into the deeper periodontal structures. A minimum width of approximately 2 millimeters of keratinized tissue is generally recommended by clinicians around both natural teeth and implants to maintain tissue stability, reduce inflammation, and support long-term oral health.

When insufficient keratinized tissue is present, patients face increased risk of gingival recession, plaque accumulation, chronic inflammation, and implant complications. Soft tissue grafting procedures, including free gingival grafts (D4270) and connective tissue grafts (D4273), are performed to augment the band of keratinized tissue and establish a stable soft tissue environment. These procedures are particularly important around dental implants, where inadequate keratinized tissue has been associated with higher rates of peri-implant mucositis and bone loss.

Revenue cycle teams should note that soft tissue grafting claims for keratinized tissue augmentation require meticulous documentation to secure insurance approval. Most carriers classify these procedures under periodontics and require pre-authorization supported by clinical photographs, tissue width measurements at the deficient site, and a narrative explaining the medical necessity for grafting. Claims submitted without this documentation are routinely denied or pended for additional information. Billing teams should ensure that the treating clinician records keratinized tissue measurements and captures intraoral photographs before the grafting procedure, as reconstructing this documentation after a denial is both time-consuming and less credible to the reviewing payer. Practices that build these documentation steps into their surgical workflow achieve higher first-pass approval rates on grafting claims.